These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1921740)

  • 1. Binding properties of monoclonal antibodies to rabies virus.
    Cusi MG; Valensin PE; Tollis M; Bracci L; Petreni S; Soldani P
    Microbiologica; 1991 Jul; 14(3):205-11. PubMed ID: 1921740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
    Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
    J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H; Coulon P; Lafay F; Flamand A
    Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
    Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
    Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel double-antigen sandwich enzyme-linked immunosorbent assay for Measurement of Antibodies against rabies virus.
    Yang LM; Zhao LZ; Hu RL; Shi ZS; Liu WJ
    Clin Vaccine Immunol; 2006 Aug; 13(8):966-8. PubMed ID: 16893999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
    Zhang S; Liu Y; Zhang F; Hu R
    Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.
    Metlin AE; Cox J; Rybakov SS; Huovilainen A; Grouzdev KN; Neuvonen E
    J Vet Med B Infect Dis Vet Public Health; 2004 Mar; 51(2):94-6. PubMed ID: 15030608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakage in alpha-helix: a recognition site for anti-rabies virus ribonucleoprotein antibody.
    Otvos L; Dietzschold B; Hollosi M; Gore M; Kajtar J; Niu H; Koprowski H
    Pept Res; 1989; 2(2):167-70. PubMed ID: 2520753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent.
    He Y; Gao D; Zhang M
    J Virol Methods; 2006 Dec; 138(1-2):147-51. PubMed ID: 17034869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantitative assay of rabies post-vaccination antibody by ELISA.
    Karamany RM; Kazar J; Malik SA; al-Mufti S; Badriya M
    APMIS Suppl; 1988; 3():40-3. PubMed ID: 3179075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rabies in dogs experimentally infected with street virus and immunized with Flury LEP virus thereafter (author's transl)].
    Weinhold E; Scholz M; Leuchte S
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):288-95. PubMed ID: 4150062
    [No Abstract]   [Full Text] [Related]  

  • 15. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 16. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.
    Toacsen E; Serban O; Moraru S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):333-9. PubMed ID: 7340722
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular tests for assessing the immunogenicity of rabies vaccines.
    Kiss Z; Tuboly S
    Acta Vet Acad Sci Hung; 1981; 29(4):349-58. PubMed ID: 7053012
    [No Abstract]   [Full Text] [Related]  

  • 19. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
    Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
    Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
    van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.